Dr. Bert is interested in convening conversations across medical disciplines, and is currently designing a trial to make patients undergoing injectable retina treatment more comfortable.
Recent Posts
- Fall 2024 InSight Newsletter
- The Complement Factor H (Y402H) risk polymorphism for age-related macular degeneration affects metabolism and response to oxidative stress in the retinal pigment epithelium
- Three Doheny Doctors are LA Times’ Orange County Visionaries 2024
- Three Doheny Doctors are LA Times’ Orange County Visionaries 2024
- InSight at a Glance | October 2024